UNSPSC 51161500: Antiasthmatic drugs

This classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.

UNSPSC 51161500 Antiasthmatic drugs is a Class code under which state and local governments procure generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing vehicles. State procurement offices and multistate cooperative alliances issue these solicitations to establish master contracts with pharmaceutical manufacturers and suppliers, who then deliver products through authorized wholesale distributors to state agencies, local health departments, school districts, correctional facilities, and other public health and safety entities. The scope encompasses branded and generic pharmaceutical products with specific National Drug Codes, requiring vendors to maintain compliance with current Good Manufacturing Practices, the Drug Supply Chain Security Act, and FDA labeling and expiration requirements, and to support electronic data interchange ordering and chargeback systems with authorized wholesalers.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The solicitation covers participating state and local facilities in Minnesota and Oregon, with awarded vendors required to supply products through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Evaluation criteria prioritize price competitiveness (75 percent), fixed pricing for the contract term (10 percent), and administrative compliance including EDI capability, agreement to a 3 percent administrative fee, and proper data formatting (15 percent combined). Contract terms run two years for new vendors with optional extensions, or align with existing expiration dates through June 30, 2028 for incumbent responders, with performance penalties ranging from $200 to $1,500 per violation.